⚕ GalenOps CRO console
← 710 (USA)

710-1278

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 710 (USA) (Dr. Silva) · consented 2012-12-24
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate BURNING SENSATION — outcome: RECOVERED/RESOLVED; onset 2013-02-24 (study day 63.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-07 (study day 46.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-02-07 (study day 46.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild SOMNOLENCE — outcome: RECOVERED/RESOLVED; onset 2013-01-13 (study day 21.0); relationship: REMOTE

mild assessed 2026-08-18

Mild VOMITING — outcome: RECOVERED/RESOLVED; onset 2013-03-02 (study day 69.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.